Table III.
Association between 97 patients with lung adenocarcinoma stratified according to histopathological score and the SUVmax, LVI and EGFR mutation status of these patients.
| Hisbottomathological score, n (%) | ||||
|---|---|---|---|---|
| Characteristic | Low (n=40) | Intermediate (n=40) | High (n=17) | P-value |
| SUVmax | 0.005 | |||
| <4.4 | 27 (67.5) | 17 (42.5) | 4 (23.5) | |
| ≥4.4 | 13 (32.5) | 23 (57.5) | 13 (76.5) | |
| LVI | 0.008 | |||
| Negative | 25 (62.5) | 20 (50.0) | 3 (17.6) | |
| Positive | 15 (37.5) | 20 (50.0) | 14 (82.4) | |
| EGFR mutation | 0.005 | |||
| Negative | 14 (35.0) | 27 (67.5) | 12 (70.6) | |
| Positive | 26 (65.0) | 13 (32.5) | 5 (29.4) | |
SUVmax, maximum standardized uptake value; LVI, lymphovascular invasion; EGFR, epidermal growth factor receptor.